Published in Allergy on May 01, 1994
Strategies of mucosal immunotherapy for allergic diseases. Cell Mol Immunol (2011) 0.81
Local nasal immunotherapy. Allergy (1995) 0.75
Local nasal specific immunotherapy for allergic rhinitis. Allergy Asthma Clin Immunol (2006) 0.75
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics (1995) 2.87
Symptoms of bronchial hyperreactivity and asthma in relation to environmental factors. Arch Dis Child (1988) 2.47
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J (2004) 2.36
Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. European Society of Pediatric Allergy and Clinical Immunology. Pediatr Allergy Immunol (1993) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis. Infect Immun (1979) 2.08
Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy (1999) 1.86
Interaction of E. coli strains with human serum: lack of relationship to K1 antigen. J Pediatr (1976) 1.83
Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy (2003) 1.79
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy (2011) 1.66
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy (2009) 1.61
Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol (1997) 1.60
Cord blood levels of immunoglobulin G subclass antibodies to food and inhalant allergens in relation to maternal atopy and the development of atopic disease during the first 8 years of life. Clin Exp Allergy (2000) 1.58
Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy (2009) 1.58
Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J (2000) 1.57
Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden. Clin Exp Allergy (1998) 1.50
Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria. Infect Immun (1978) 1.50
Thymus size and head circumference at birth and the development of allergic diseases. Clin Exp Allergy (2001) 1.48
Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J (2001) 1.46
Immune responses to birch in young children during their first 7 years of life. Clin Exp Allergy (2002) 1.43
Fatty acid composition in colostrum and mature milk from non-atopic and atopic mothers during the first 6 months of lactation. Acta Paediatr (1998) 1.42
Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy (2014) 1.41
Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy (2000) 1.35
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol (2009) 1.30
The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers. Pediatrics (1979) 1.30
A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch Pediatr Adolesc Med (1998) 1.29
Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy (1995) 1.26
Collecting and banking human milk: to heat or not to heat? Br Med J (1980) 1.25
Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B. Infect Immun (1976) 1.25
Interaction of Escherichia coli with different fimbriae and polymorphonuclear leukocytes. Infect Immun (1982) 1.23
Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr (1978) 1.19
Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy (2005) 1.19
Pustulosis palmoplantaris and its relation to chronic recurrent multifocal osteomyelitis. Dermatologica (1979) 1.17
Increased IgE antibody responses in rats exposed to tobacco smoke. J Allergy Clin Immunol (1985) 1.16
Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res (2000) 1.15
Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health (2001) 1.14
Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch Dis Child (1997) 1.14
An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol (2000) 1.13
The precision of the conjunctival provocation test. Allergy (1984) 1.13
The prevalence of allergy and IgE antibodies to inhalant allergens in Swedish school children. Acta Paediatr Scand (1987) 1.12
Nasal metachromatic cells in infancy in relation to the appearance of atopic disease during the first 6 years of life. Allergy (1997) 1.12
Risk factors for respiratory symptoms and atopic sensitisation in the Baltic area. Arch Dis Child (1995) 1.11
Neutropenia induced by systemic infusion of lactoferrin. J Lab Clin Med (1982) 1.11
Distinct pattern of commensal gut microbiota in toddlers with eczema. Int Arch Allergy Immunol (2006) 1.10
Atopic sensitization and respiratory symptoms among Polish and Swedish school children. Clin Exp Allergy (1994) 1.08
International variation in prevalence of rhinitis and its relationship with sensitisation to perennial and seasonal allergens. Eur Respir J (2008) 1.05
Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age. Clin Exp Allergy (2002) 1.04
Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol (1993) 1.03
High body mass index, asthma and allergy in Swedish schoolchildren participating in the International Study of Asthma and Allergies in Childhood: Phase II. Acta Paediatr (2003) 1.01
Limiting factors in bacterial phagocytosis by human polymorphonuclear leukocytes. Acta Pathol Microbiol Scand C (1977) 1.01
Cat (Fel d I), dog (Can f I), and cockroach allergens in homes of asthmatic children from three climatic zones in Sweden. Allergy (1994) 1.01
Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr Res (1977) 1.00
Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect Immun (1991) 0.98
Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatr Res (2000) 0.98
Adverse reactions to food and food allergy in young children in Iceland and Sweden. Scand J Prim Health Care (1999) 0.97
Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol (1994) 0.97
Translation of questions: the International Study of Asthma and Allergies in Childhood (ISAAC) experience. Int J Tuberc Lung Dis (2009) 0.96
Clinical symptoms and IgE responses to common food proteins and inhalants in the first 7 years of life. Clin Allergy (1987) 0.96
Effect of maternal avoidance of eggs, cow's milk and fish during lactation upon allergic manifestations in infants. Clin Exp Allergy (1989) 0.96
Sensitizing ability of derivatives of picryl chloride after exposure of mice on the skin and in the lung. Int Arch Allergy Appl Immunol (1983) 0.95
Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine (1995) 0.95
International variations in associations of allergic markers and diseases in children: ISAAC Phase Two. Allergy (2009) 0.94
Effect of breastfeeding on asthma, lung function and bronchial hyperreactivity in ISAAC Phase II. Eur Respir J (2009) 0.94
Childhood asthma and exposure to indoor allergens: low mite levels are associated with sensitivity. Pediatr Allergy Immunol (1996) 0.93
Season of birth as predictor of atopic manifestations. Arch Dis Child (1997) 0.93
Association and linkage of atopic dermatitis with chromosome 13q12-14 and 5q31-33 markers. J Invest Dermatol (2000) 0.92
Influence of type of feeding on lymphocyte function and development of infantile allergy. Clin Allergy (1982) 0.92
Immune responses in rats sensitized with aerosolized antigen. Antibody formation, lymphoblastic responses and mast cell and mucous cell development related to bronchial reactivity. Int Arch Allergy Appl Immunol (1983) 0.91
High-dose exposure to cat is associated with clinical tolerance--a modified Th2 immune response? Clin Exp Allergy (2003) 0.91
Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine. Int Arch Allergy Appl Immunol (1989) 0.91
Human milk polyunsaturated long-chain fatty acids and secretory immunoglobulin A antibodies and early childhood allergy. Pediatr Allergy Immunol (2000) 0.90
Atopy among schoolchildren in northern and southern Sweden in relation to pet ownership and early life events. Pediatr Allergy Immunol (2001) 0.90
The prevalence of asthmatic respiratory symptoms among adults in Estonian and Swedish university cities. Allergy (1996) 0.90
Clinical symptoms and IgE responses to common food proteins in atopic and healthy children. Clin Allergy (1984) 0.90
Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy (2013) 0.89
Characterization of the mouse and rat IgE antibody responses to timothy pollen by means of crossed radioimmunoelectrophoresis. Allergy (1982) 0.89
Detection of Fel d 1-immunoglobulin G immune complexes in cord blood and sera from allergic and non-allergic mothers. Pediatr Allergy Immunol (2001) 0.89
Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. Allergy (1994) 0.89
Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis. Allergy (1989) 0.88
Statistical aspects of cell motility determinations with a modified chemotaxis assembly for multiwell filter assays. J Immunol Methods (1981) 0.88
Poliomyelitis-like illness associated with asthma. Arch Dis Child (1980) 0.88
Atopic sensitization during the first year of life in relation to long chain polyunsaturated fatty acid levels in human milk. Pediatr Res (1998) 0.88
Mite allergens in relation to home conditions and sensitization of asthmatic children from three climatic regions. Allergy (1995) 0.87
Zinc and immune function in Down's syndrome. Acta Paediatr Scand (1980) 0.87
Polyunsaturated n-3 fatty acids and the development of atopic disease. Lipids (2001) 0.87
Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses. Pediatr Allergy Immunol (1999) 0.87
Mite (Der p 1, Der f 1) and cat (Fel d 1) allergens in the homes of babies with a family history of allergy. Allergy (1993) 0.86
Atopic sensitization and atopic dermatitis in Estonian and Swedish infants. Clin Exp Allergy (2005) 0.86
Expression of and responses to CD2 and CD3 in 18-month-old children with and without atopic dermatitis. Pediatr Allergy Immunol (2000) 0.86
Development of immunoglobulin G subclass antibodies to ovalbumin, birch and cat during the first eight years of life in atopic and non-atopic children. Pediatr Allergy Immunol (1999) 0.86
Exposure to indoor allergens in early infancy and sensitization. J Allergy Clin Immunol (1997) 0.86
Enzymes of leukocyte oxidative metabolism in Down's syndrome. Acta Paediatr Scand (1984) 0.86
Serum IgE in infants and influence of type of feeding. Clin Allergy (1980) 0.85
Familial occurrence of histiocytosis. Clin Genet (1977) 0.85
Induction of humoral immunity and pulmonary mast cells in mice and rats after immunization with aerosolized antigen. Immunology (1983) 0.85
Development of allergy and IgE antibodies during the first five years of life in Estonian children. Clin Exp Allergy (2001) 0.85
The gut microbiota: a complex ecosystem. Clin Exp Allergy (2006) 0.84